Isaszeg, Hungary

Balázs Molnár

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 11.9

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Balázs Molnár

Introduction

Balázs Molnár, an accomplished inventor based in Isaszeg, Hungary, has made significant contributions to the field of medicinal chemistry. With three patents to his name, Molnár's work is characterized by his focus on developing therapeutic compounds that target critical biological pathways.

Latest Patents

His latest inventions include a series of innovative compounds. The first, titled "Substituted piperidines as inhibitors of ubiquitin specific protease 7," describes compounds of formula (I), wherein R, R, R, B, W, Z, m, and n are defined in the description. The second patent, "Substituted piperidines for the treatment of cancer," explores compounds of formula (I) as well, specifically focusing on R, R, R, n, and W as defined. Additionally, he has developed medicinal products that are beneficial in treating conditions requiring pro-apoptotic and/or anti-proliferative agents.

Career Highlights

Throughout his career, Balázs Molnár has collaborated with well-known companies in the pharmaceutical sector. Notably, he has worked at Les Laboratoires Servier and Vernalis (R&D) Limited. His time at these institutions allowed him to translate his innovative ideas into practical applications that address critical health challenges.

Collaborations

Molnár has engaged with numerous talented individuals during his career, including colleagues András Kotschy and Csaba Wéber. Their combined expertise and collaborative efforts have likely contributed to the success of his inventive projects.

Conclusion

As an inventor, Balázs Molnár exemplifies the spirit of innovation that drives advancements in medicinal chemistry. His patents not only demonstrate his scientific acumen but also hold potential for significant impacts in the treatment of serious medical conditions. Through his collaborations and career experiences, he continues to push the boundaries of research and development in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…